Silgan (NYSE:SLGN) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Silgan (NYSE:SLGN) posted its quarterly earnings results on Wednesday. The industrial products company reported $0.98 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.02, Zacks reports. Silgan had a net margin of 4.31% and a return on equity of 17.22%. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the company earned $1.01 earnings per share. Silgan updated its FY 2026 guidance to 3.730-3.930 EPS and its Q3 2026 guidance to 1.210-1.310 EPS.

Here are the key takeaways from Silgan’s conference call:

• 2026 guidance was reaffirmed: Silgan maintained its adjusted EPS outlook of $3.73–$3.93, free cash flow estimate of approximately $450 million, and low- to mid-single-digit adjusted EBIT growth expectations.
• Management expects stronger second-half performance, including third-quarter volume growth across all segments on a comparable basis. Metal Containers volumes are expected to grow low- to mid-single digits in the third quarter, supported by wet pet food growth and the timing of vegetable-container orders.
• Second-quarter sales rose 7% to approximately $1.6 billion, but adjusted EBIT declined 4% to $185 million and adjusted EPS fell to $0.98 from $1.01. Higher raw-material pass-throughs and favorable interest expense helped offset operational and corporate-cost pressures.
• Dispensing and Specialty Closures faced a 15% volume decline in Brazil, contributing to a 1% segment volume decline and an approximately $5 million impact from lower volume and mix. Management expects recovery to begin in the fourth quarter, with full recovery projected by 2027.
• Wet pet food volumes increased 7% year over year, while Custom Containers EBIT improved despite lower reported volumes due to footprint-optimization savings and favorable price-over-cost. Fine fragrance and healthcare products also remain key longer-term growth areas, with substantial 2027 healthcare and fragrance business already contractualized or in commercialization.

Silgan Stock Performance

Shares of NYSE:SLGN traded down $5.44 during midday trading on Wednesday, reaching $42.57. 1,886,092 shares of the company traded hands, compared to its average volume of 976,712. The firm’s fifty day moving average price is $42.38 and its two-hundred day moving average price is $42.51. The firm has a market capitalization of $4.50 billion, a price-to-earnings ratio of 15.98, a price-to-earnings-growth ratio of 2.56 and a beta of 0.66. The company has a quick ratio of 0.78, a current ratio of 1.26 and a debt-to-equity ratio of 1.58. Silgan has a 12 month low of $35.68 and a 12 month high of $51.79.

Silgan Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were paid a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date was Monday, June 1st. Silgan’s payout ratio is presently 31.58%.

Silgan News Summary

Here are the key news stories impacting Silgan this week:

• Positive Sentiment: Silgan reported second-quarter EPS of $0.98, exceeding the consensus estimate of $0.96. Revenue also surpassed expectations and rose 6.8% from the same quarter last year. Silgan Holdings Q2 Earnings and Revenues Surpass Estimates
• Positive Sentiment: Full-year 2026 EPS guidance of $3.73-$3.93 has a midpoint of $3.83, slightly above the analyst consensus of $3.80, suggesting the company remains broadly on track with expectations. Silgan Announces Second Quarter 2026 Results
• Neutral Sentiment: Analysts have set an average price target of $53 for Silgan, implying potential upside if the company executes on its outlook. However, the target reflects existing analyst views rather than a new earnings-related estimate revision. Analysts Set Silgan Holdings Target Price at $53
• Negative Sentiment: Second-quarter EPS fell to $0.98 from $1.01 a year earlier, meaning profit growth lagged the reported increase in revenue. Silgan Q2 Earnings Key Metrics Versus Estimates
• Negative Sentiment: Third-quarter EPS guidance of $1.21-$1.31 has a midpoint of $1.26, below the $1.28 consensus estimate. The modest shortfall may be weighing on the shares more than the second-quarter beat is supporting them.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. increased its position in shares of Silgan by 22.1% during the fourth quarter. JPMorgan Chase & Co. now owns 9,274,095 shares of the industrial products company’s stock valued at $374,395,000 after buying an additional 1,676,760 shares during the period. Wellington Management Group LLP boosted its position in shares of Silgan by 25.8% in the third quarter. Wellington Management Group LLP now owns 5,604,993 shares of the industrial products company’s stock valued at $241,071,000 after acquiring an additional 1,148,044 shares during the period. Dimensional Fund Advisors LP grew its stake in Silgan by 17.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 4,387,955 shares of the industrial products company’s stock valued at $177,144,000 after acquiring an additional 647,558 shares in the last quarter. State Street Corp increased its holdings in Silgan by 0.7% during the 2nd quarter. State Street Corp now owns 3,646,093 shares of the industrial products company’s stock worth $197,545,000 after acquiring an additional 23,734 shares during the period. Finally, Fuller & Thaler Asset Management Inc. increased its holdings in Silgan by 177.3% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 3,400,088 shares of the industrial products company’s stock worth $137,262,000 after acquiring an additional 2,174,028 shares during the period. Hedge funds and other institutional investors own 70.25% of the company’s stock.

Analyst Upgrades and Downgrades

SLGN has been the topic of a number of research reports. UBS Group dropped their price objective on Silgan from $46.00 to $44.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 5th. JPMorgan Chase & Co. cut their price target on Silgan from $53.00 to $47.00 and set an “overweight” rating for the company in a research note on Thursday, April 30th. Truist Financial lowered their price objective on Silgan from $54.00 to $52.00 and set a “buy” rating on the stock in a research note on Thursday, April 30th. Weiss Ratings upgraded shares of Silgan from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, July 15th. Finally, Citigroup reduced their target price on shares of Silgan from $56.00 to $54.00 and set a “buy” rating for the company in a research note on Thursday, April 30th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $53.00.

Silgan Company Profile

Silgan Holdings Inc (NYSE: SLGN) is a leading supplier of rigid packaging solutions for consumer goods manufacturers. The company’s core business activities center on the design, production and distribution of metal and plastic containers, closures and dispense systems. Silgan serves a broad array of end markets, including food and beverage, home and personal care, health care and industrial products, providing both standard and custom packaging formats.

Founded in 1987 and headquartered in Stamford, Connecticut, Silgan has grown organically and through strategic acquisitions to establish a global manufacturing footprint.